Guardant Health
GH
#1449
Rank
ยฃ11.34 B
Marketcap
ยฃ85.56
Share price
17.09%
Change (1 day)
187.26%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -ยฃ2.52

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.52. In 2025 the company made an earnings per share (EPS) of -ยฃ2.46 an increase over its 2024 EPS that were of -ยฃ2.65.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.522.2%
2025-ยฃ2.46-7.02%
2024-ยฃ2.65-16.82%
2023-ยฃ3.19-33.13%
2022-ยฃ4.7660%
2021-ยฃ2.9855.04%
2020-ยฃ1.92207.14%
2019-ยฃ0.63-19.81%
2018-ยฃ0.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ2.09-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.85-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA